![Mark Oki](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Oki
Director of Finance/CFO at
NEOS THERAPEUTICS, INC.
Net worth: 1 M $ as of 2026-08-30
Profile
Mark K.
Oki is currently Chief Financial Officer at Neos Therapeutics, Inc. and Chief Financial Officer at Achieve Life Sciences, Inc. Formerly, Mr. Oki was Chief Financial Officer, Secretary & Treasurer at Aytu Biopharma, Inc. from 2022 to 2024; Chief Financial & Accounting Officer at VIVUS, Inc. from 2015 to 2019; CFO, Secretary & Senior VP-Finance at Alexza Pharmaceuticals, Inc. in 2015; Controller at Pharmacyclics LLC in 2006; and Assistant Controller at Incyte Corp.
from 1998 to 2001.
Education includes an undergraduate degree from San Jose State University conferred in 1991.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-01-27 | 127,940 ( 0.12% ) | 1 M $ | 2026-08-30 |
Mark Oki active positions
| Companies | Position | Start |
|---|---|---|
| NEOS THERAPEUTICS, INC. | Director of Finance/CFO | - |
| ACHIEVE LIFE SCIENCES, INC. | Director of Finance/CFO | 2024-12-04 |
Former positions of Mark Oki
| Companies | Position | End |
|---|---|---|
| AYTU BIOPHARMA, INC. | Director of Finance/CFO | 2024-11-10 |
| ALEXZA PHARMACEUTICALS, INC. | Director of Finance/CFO | 2015-10-15 |
| PHARMACYCLICS, INC. | Comptroller/Controller/Auditor | 2006-03-31 |
| INCYTE CORPORATION | Corporate Officer/Principal | 2000-12-31 |
| VIVUS, INC. | Director of Finance/CFO | - |
Training of Mark Oki
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
68
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes next-generation therapies | Health Technology |
Alexza Pharmaceuticals, Inc.
 Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the acute treatment of central nervous system conditions | Health Technology |
San Jose State University
 San Jose State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neos Therapeutics, Inc.
 Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets central nervous system-focused products | Health Technology |
Aytu Biopharma, Inc.
 Aytu Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Achieve Life Sciences, Inc.
 Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
- Stock Market
- Insiders
- Mark Oki
